USPTO serial 88209721
MAGSENSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- NUNLEY, CHRISTOPHER MICHAEL
- Law office
- TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MAGSENSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
V Gerald Grafe
V GERALD GRAFE THE GRAFE LAW OFFICE PCPO BOX 2689CORRALES, NM 87048UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Preparations containing superparamagnetic nanoparticles for medical use in the nature of diagnostic preparations that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments; preparations containing superparamagnetic nanoparticles for medical use in that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments for detecting cancer; syringes prefilled with preparations containing superparamagnetic nanoparticles for medical use in in the nature of diagnostic preparations that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments; syringes prefilled with preparations containing superparamagnetic nanoparticles for medical use in that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments for detecting cancer; kits containing preparations containing superparamagnetic nanoparticles for medical use in in the nature of diagnostic preparations that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments, and also containing syringes prefilled with such preparations; kits containing preparations containing superparamagnetic nanoparticles for medical use in that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments for detecting cancer; cancer test kits containing preparations containing superparamagnetic nanoparticles for medical use in in the nature of diagnostic preparations that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments; cancer test kits containing preparations containing superparamagnetic nanoparticles for medical use in that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments for detecting cancer; and medical instrument systems, used for in vivo medical imaging or for the diagnosis or screening of cancer, for determination of one or more of the presence, the location, and the quantity of one or more of cells, cancerous growths, and proteins in the human body, comprising magnetic sensors sensitive to nanoparticles introduced into the human body; all of the foregoing not for use in diagnostic testing for cardiovascular diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 19, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 18, 2019 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 18, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 4, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 17, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |